V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011638 | 240007838 | 1.8 | 75.6 | Neo-adjuvant (N) | 2017-09-11 | 2017-09-11 | Carboplatin AUC 2 - 5 | N | N | 240031447 | CARBOPLATIN |
| 240011640 | 240012207 | 1.56 | 50.9 | Palliative (P) | 2017-03-16 | 2017-03-17 | INTERLACE TRIAL | 2 | null | 240031496 | INTERLACE TRIAL |
| 240011641 | 240007842 | 1.8 | 75.6 | Palliative (P) | 2015-10-08 | 2015-10-09 | SMILE | Y | N | 240031499 | TRIAL |
| 240011642 | 240012208 | 1.69 | 19.4 | Palliative (P) | 2015-08-10 | 2015-11-02 | Bevacizumab | N | N | 240031503 | BEVACIZUMAB |
| 240011643 | 240007847 | 1.62 | 31 | null | 2015-07-13 | 2015-08-03 | CHOP | N | N | 240031504 | CHOP |
| 240011644 | 240014261 | 1.63 | null | Curative (C) | 2016-08-10 | 2016-08-29 | INTERLACE TRIAL | N | N | 240031506 | INTERLACE TRIAL |
| 240011645 | 240014261 | 1.78 | 69 | Neo-adjuvant (N) | 2015-09-25 | 2015-10-02 | NHL Int B NHL rit 2010 | 02 | N | 240031506 | NOT MATCHED |
| 240011646 | 240007850 | null | null | Palliative (P) | 2014-05-04 | 2014-05-26 | CARBOPLATIN | 02 | N | 240031519 | CARBOPLATIN |
| 240011648 | 240007851 | 1.74 | null | Palliative (P) | 2017-04-17 | 2017-07-10 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 240031537 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011649 | 240007852 | null | 62 | Curative (C) | 2014-09-29 | 2014-12-08 | Paclitaxel 7 day | N | N | 240031537 | PACLITAXEL |
| 240011650 | 240007852 | 1.53 | 44.8 | Palliative (P) | null | 2017-11-18 | Methotrexate intrathecal | 02 | N | 240031537 | METHOTREXATE INTRATHECAL |
| 240011651 | 240007853 | 1.54 | 50.8 | Palliative (P) | 2017-03-07 | 2017-03-08 | Methotrexate intrathecal | 1 | null | 240031559 | METHOTREXATE INTRATHECAL |
| 240011652 | 240007854 | 1.65 | 58 | Palliative (P) | 2015-10-04 | 2015-10-10 | HD EuroNet-PHL-C1 Relapsed BEAM | N | N | 240031562 | NOT MATCHED |
| 240011653 | 240012213 | null | 65 | Disease modification (D) | 2017-10-02 | 2017-10-02 | Trial Unspecified | N | N | 240031562 | TRIAL |
| 240011654 | 240012213 | 1.63 | 52 | Adjuvant (A) | 2016-10-25 | 2016-11-12 | Azacitidine | 02 | N | 240031562 | AZACITIDINE |
| 240011655 | 240015832 | 1.63 | 0 | Curative (C) | 2015-12-31 | 2016-01-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | 240031603 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011656 | 240007855 | 1.67 | 117 | Curative (C) | 2015-07-18 | 2015-07-30 | INTERLACE TRIAL | 02 | N | 240031605 | INTERLACE TRIAL |
| 240011658 | 240007858 | 1.57 | 69.5 | Disease modification (D) | 2011-09-06 | 2015-06-09 | Carboplatin AUC 2 - 5 | N | N | 240031621 | CARBOPLATIN |
| 240011659 | 240007859 | 1.64 | 55.3 | Curative (C) | 2017-10-02 | 2017-10-11 | Carboplatin AUC 2 - 5 | 1 | N | 240031626 | CARBOPLATIN |
| 240011660 | 240012214 | 1.68 | 91 | Palliative (P) | 2014-05-22 | 2014-05-22 | Trial Unspecified | 2 | null | 240031626 | TRIAL |
| 240011661 | 240007860 | 1.88 | 112 | Adjuvant (A) | 2014-03-14 | 2014-03-21 | INTERLACE TRIAL | 01 | N | 240031634 | INTERLACE TRIAL |
| 240011662 | 240012215 | 1.74 | null | Palliative (P) | 2014-03-21 | 2014-04-01 | Bevacizumab 7.5mg/kg | N | N | 240031639 | BEVACIZUMAB |
| 240011663 | 240007862 | 1.55 | null | Not known (9) | null | 2017-09-23 | Methotrexate intrathecal | 02 | null | 240031645 | METHOTREXATE INTRATHECAL |
| 240011664 | 240007863 | null | null | Neo-adjuvant (N) | null | 2013-04-11 | INTERLACE TRIAL | N | N | 240031652 | INTERLACE TRIAL |
| 240011665 | 240007867 | 1.88 | 90.4 | Curative (C) | 2016-01-15 | 2017-12-31 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031659 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011666 | 240007868 | 1.71 | 80.1 | Curative (C) | 2016-09-19 | 2016-10-05 | CHOP - 21 days | Y | N | 240031664 | CHOP |
| 240011667 | 240012220 | null | 72.5 | Adjuvant (A) | null | 2016-07-21 | Azacitidine | N | N | 240031665 | AZACITIDINE |
| 240011668 | 240012220 | 0 | null | Curative (C) | 2013-04-20 | 2013-04-27 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240031665 | NOT MATCHED |
| 240011669 | 240007872 | null | 54.4 | Palliative (P) | 2017-01-18 | 2017-01-27 | Carboplatin AUC 2 - 5 | null | null | 240031675 | CARBOPLATIN |
| 240011670 | 240007873 | 1.62 | 21.8 | Curative (C) | 2017-07-30 | 2017-07-30 | CARBOPLATIN | N | N | 240031676 | CARBOPLATIN |
| 240011671 | 240007874 | 1.7 | 65.8 | Palliative (P) | 2016-07-24 | 2016-08-03 | Bevacizumab 15mg/kg | N | null | 240031678 | BEVACIZUMAB |
| 240011672 | 240007876 | 1.57 | 75.7 | Neo-adjuvant (N) | 2014-03-20 | 2014-03-20 | CHOP R + Cytarabine High Dose | null | N | 240031686 | NOT MATCHED |
| 240011673 | 240007876 | 1.63 | 114.7 | Curative (C) | 2018-01-08 | 2018-01-23 | Trial Unspecified | N | N | 240031686 | TRIAL |
| 240011674 | 240007877 | 1.72 | null | Palliative (P) | 2019-01-28 | 2019-02-24 | Trial Unspecified | 02 | N | 240031695 | TRIAL |
| 240011675 | 240014270 | 1.64 | 64.7 | null | 2016-02-25 | 2016-02-25 | Azacitidine | 02 | null | 240031695 | AZACITIDINE |
| 240011676 | 240014270 | null | 31.4 | Palliative (P) | 2015-09-15 | 2015-09-15 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240031695 | NOT MATCHED |
| 240011677 | 240012224 | 1.63 | 53 | Palliative (P) | null | 2014-10-18 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240031703 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011678 | 240007880 | 1.62 | 55.2 | Palliative (P) | 2013-05-02 | 2013-10-23 | Carboplatin AUC 2 - 5 | N | N | 240031711 | CARBOPLATIN |
| 240011679 | 240007882 | 1.45 | 50.9 | Palliative (P) | 2018-09-20 | 2018-10-04 | Carboplatin AUC 2 - 5 | N | N | 240031714 | CARBOPLATIN |
| 240011680 | 240007883 | 1.67 | 47.5 | Curative (C) | 2016-12-25 | 2017-01-03 | NHL IntB NHL ritux2010 GpB COPADM R | N | N | 240031716 | NOT MATCHED |
| 240011681 | 240007884 | 1.77 | 36.8 | null | null | 2017-08-14 | PACLITAXEL | N | N | 240031717 | PACLITAXEL |
| 240011682 | 240012227 | 1.52 | 70 | Palliative (P) | 2014-05-28 | 2014-06-28 | Trial Unspecified | N | N | 240031719 | TRIAL |
| 240011683 | 240007885 | 1.74 | 68.3 | Neo-adjuvant (N) | null | 2014-11-30 | INTERLACE TRIAL | N | N | 240031720 | INTERLACE TRIAL |
| 240011684 | 240007886 | 1.7 | 86 | Neo-adjuvant (N) | 2018-05-16 | 2018-05-19 | INTERLACE TRIAL | 2 | N | 240031720 | INTERLACE TRIAL |
| 240011685 | 240007888 | 1.69 | 75.6 | Palliative (P) | 2014-12-13 | 2014-12-13 | ALCL ALCL 99 Closed BM 1, 2 or 3 | Y | N | 240031729 | NOT MATCHED |
| 240011686 | 240007890 | 1.62 | 100 | Curative (C) | 2018-12-30 | 2018-12-30 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 2 | N | 240031732 | NOT MATCHED |
| 240011687 | 240007892 | 1.75 | 84 | Disease modification (D) | 2016-10-22 | 2016-10-30 | Azacitidine | N | N | 240031735 | AZACITIDINE |
| 240011688 | 240007896 | 1.67 | 0 | Neo-adjuvant (N) | 2016-05-28 | 2016-06-05 | Bevacizumab 15mg/kg | N | N | 240031746 | BEVACIZUMAB |
| 240011689 | 240007899 | 1.84 | 78.9 | Curative (C) | 2016-04-15 | 2016-05-02 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | N | 240031748 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011690 | 240007902 | null | 0 | Disease modification (D) | 2014-07-16 | 2014-07-18 | Trial Unspecified | N | N | 240031753 | TRIAL |